Analysis of telomerase activity levels in breast cancer: Positive detection at the in situ breast carcinoma stage

Clinical Cancer Research

Volumn 3, Issue 1, 1997, Pages 11-16

  Bednarek, Andrzej K ^a   Sahin, Aysegul ^b   Brenner, Andrew J ^a   Johnston, Dennis A ^b   Aldaz, C Marcelo ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR; TELOMERASE;

ARTICLE; BREAST CANCER; CANCER STAGING; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPH NODE METASTASIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; TUMOR VOLUME;

BREAST NEOPLASMS; CARCINOMA IN SITU; HUMANS; NEOPLASM STAGING; PROGNOSIS; TELOMERASE; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL;

EID: 0031041774     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Greider, C. W., and Blackburn, E. H. The telomere terminal transferase of tetrahymena is a ribonucleoprotein enzyme with two kinds of primer specificity. Cell, 51: 887-898, 1987.
2. Morin, G. B. The human telomere terminal transferase enzyme is a ribonucleoprotein that synthesizes TTAGGG repeats. Cell, 59: 521-529, 1989.
3. Feng, J., Funk, W. D., Wang, S-S., Weinrich, S. L., Avilion, A. A., Chiu, C-P., Adams, R. R., Chang, E., Allsopp, R. C., Yu, J., Le, S., West, M. D., Harley, C. B., Andrews, W. H., Greider, C. W., and Villeponteau, B. The RNA component of human telomerase. Science (Washington DC), 269: 1236-1241, 1995.
4. Holt, S. E., Shay, J. W., and Wright, W. E. Refining the telomere- telomerase hypothesis of aging and cancer. Nat. Biotechnol., 14: 836- 839, 1996.
5. Kim, N. W., Piatyszek, M. A., Prowse, K. R., Harley, C. B., West, M. D., Ho, P. L. C., Coviello, G. M., Wright, W. E., Weinrich, S. L., and Shay, J. W. Specific association of human telomerase activity with immortal cells and cancer. Science (Washington DC), 266: 2011-2015, 1994.
6. Counter, C. M., Hirte, H. W., Bacchetti, S., and Harley, C. B. Telomerase activity in human ovarian carcinoma. Proc. Natl. Acad. Sci. USA, 91: 2900-2904, 1994.
7. Hiyama, E., Yokoyama, T., Tatsumoto, N., Hiyama, K., Imamura, Y., Murakami, Y., Kodama, T., Piatyszek, M. A., Shay, J. W., and Matsuura, Y. Telomerase activity in gastric cancer. Cancer Res., 55: 3258-3262, 1995.
8. Chadeneau, C., Hay, K., Hirte, H. W., Gallinger, S., and Bacchetti, S. Telomerase activity associated with acquisition of malignancy in human colorectal cancer. Cancer Res., 55: 2533-2536, 1995.
9. Hiyama, E., Hiyama, K., Yokoyama, T., Matsuura, Y., Piatyszek, M. A., and Shay, J. W. Correlating telomerase activity levels with human neuroblastoma outcomes. Nat. Med., 1: 249-257, 1995.
10. Hiyama, K., Hiyama, E., Ishioka, S., Yamakido, M., Inai, K., Gazdar, A. F., Piatyszek, M. A., and Shay, J. W. Telomerase activity in small-cell and non-small-cell lung cancers. J. Natl. Cancer Inst., 87: 859-902, 1995.
11. Avilion, A. A., Piatyszek, M. A., Gupta, J., Shay, J. W., Bacchetti, S., and Greider, C. W. Human telomerase RNA and telomerase activity in immortal cell lines and tumor tissues. Cancer Res., 56: 645-650, 1996.
12. Hiyama, E., Gollahon, L., Kataoka, T., Kuroi, K., Yokoyama, T., Gazdar, A. F., Hiyama, K., Piatyszek, M. A., and Shay, J. W. Telomerase activity in human breast tumors. J. Natl. Cancer Inst., 88: 116- 122, 1996.
13. Sommerfeld, H-J., Meeker, A. K., Piatyszek, M. A., Bova, G. S., and Shay, J. W. Telomerase activity: a prevalent marker of malignant human prostate tissue. Cancer Res., 56: 218-222, 1996.
14. Tahara, H., Endo, H., Maeda, S., Nakanishi, T., Nagai, N., Ide, T., and Tahara, E. Telomerase activity in various precancerous and cancer tissues. Proc. Am. Assoc. Cancer Res., 37: 559, 1996.
15. Caleffi, M., Teague, M. W., Jensen, R. A., Vnencak-Jones, C. L., Dupont, W. D., and Parl, F. F. p53 gene mutations and steroid receptor status in breast cancer. Cancer (Phila.), 73: 2147-2156, 1994.
16. Ravdin, P. M., and Chamness, G. C. The c-erB-2 proto-oncogene as a prognostic and predictive marker in breast cancer: a paradigm for the development of other macromolecular markers - a review. Gene (Amst.), 159: 19-27, 1995.
17. Nakopoulou, L. L., and Alexiadou, A. Prognostic significance of the co-expression of p53 and c-erbb-2 proteins in breast cancer. J. Pathol., 179: 31-38, 1996.
18. Scholl, S., Bieche, I., Pallud, C., Champeme, M. H., Beuvon, F., and Hacene, K. Relevance of multiple biological parameters in breast cancer prognosis. Breast, 5: 21-30, 1996.
19. Beahrs, O. H., Henson, D. E., Hutter, R. V. P., and Kennedy, B. J. (eds.). American Joint Committee on Cancer. Manual for Staging of Cancer, Ed. 4. Philadelphia: J. B. Lippincott Co., 1992.
20. Piatyszek, M. A., Kim, N. W., Weinrich, S. L., Hiyama, K., Hiyama, E., Wright, W. E., and Shay, J. W. Detection of telomerase activity in human cells and tumors by a telomeric repeat amplification protocol (TRAP). Methods Cell Sci., 17: 1-15, 1995.
21. Morin, G. B. Recognition of a chromosome truncation site associated with α-thalassaemia by human telomerase. Nature (Lond.) 353: 454-456, 1991.
22. Wright, W. E., Shay, J. W., and Piatyszek, M. A. Modifications of a telomeric repeat amplification protocol (TRAP) results in increased reliability, linearity and sensitivity. Nucleic Acids Res., 23: 3794-3795, 1995.
23. Bednarek, A., Budunova, I., Slaga, T. J., and Aldaz, C. M. Increased telomerase activity in mouse skin premalignant progression. Cancer Res., 55: 4566-4569, 1995.
24. Donegan, W. L. Prognostic factors: stage and receptor status in breast cancer. Cancer (Phila.)(Suppl.), 70: 1755-1764., 1992.
25. Kim, N. W., Levitt, D., Huang, G., Wu, F., Osborne, K., and Clark, G. Correlation of telomerase with prognostic indicators of breast cancer. Proc. Am. Assoc. Cancer Res., 37: 562, 1996.
26. Hiyama, E., Gollahon, L., Kataoka, T., Kuroi, K., Yokoyama, T., Gazdar, A. F., Hiyama, K., Piatyszek, M. A., and Shay, J. W. Telomerase activity in human breast tumors. J. Natl. Cancer Inst., 88: 839- 840, 1996.